170 related articles for article (PubMed ID: 35417458)
1. Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.
Song J; Lei X; Lin H; Dai H; Liu X; Jiang Y; Hu F; Li Y; Fan H; Zhang L; Chen Z; Zhang C
PLoS One; 2022; 17(4):e0258522. PubMed ID: 35417458
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification.
Zhang JZ; Yang CX; Gao S; Bu JF; Li QQ; Wang HL; Yang KN; Tong SS; Qian LJ; Zhang J; Hua R; Sun YW; Yan JY; Chen W
World J Surg Oncol; 2023 Aug; 21(1):239. PubMed ID: 37542314
[TBL] [Abstract][Full Text] [Related]
3. How to Determine Unresectability in Hilar Cholangiocarcinoma.
Pratt CG; Whitrock JN; Shah SA; Fong ZV
Surg Clin North Am; 2024 Feb; 104(1):197-214. PubMed ID: 37953036
[TBL] [Abstract][Full Text] [Related]
4. Intravenous combined with intrabiliary contrast-enhanced ultrasound in the evaluation of resectability of hilar cholangiocarcinomas.
Jianxiong W; Yu W; Juyi W; Guangxia W
J Clin Ultrasound; 2022 Sep; 50(7):931-939. PubMed ID: 35808898
[TBL] [Abstract][Full Text] [Related]
5. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.
Zhang CW; Liu J; Hong DF; Wang ZF; Hu ZM; Huang DS; Shang MJ; Yao WF
Surg Endosc; 2018 Mar; 32(3):1581-1582. PubMed ID: 28779241
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the Bismuth-Corlette classification: Higher rates of local unresectability in stage IIIb hilar cholangiocarcinoma.
Passeri MJ; Baimas-George MR; Sulzer JK; Iannitti DA; Martinie JB; Baker EH; Ocuin LM; Vrochides D
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):157-162. PubMed ID: 32088126
[TBL] [Abstract][Full Text] [Related]
7. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
[TBL] [Abstract][Full Text] [Related]
8. [Application of 3D visualization and 3D printing in individualized precision surgery for Bismuth-Corlette type Ⅲ and Ⅳ hilar cholangiocarcinoma].
Zeng N; Yang J; Xiang N; Wen S; Zeng S; Qi S; Zhu W; Hu H; Fang C
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1172-1177. PubMed ID: 32895188
[TBL] [Abstract][Full Text] [Related]
9. MDCT assessment of resectability in hilar cholangiocarcinoma.
Ni Q; Wang H; Zhang Y; Qian L; Chi J; Liang X; Chen T; Wang J
Abdom Radiol (NY); 2017 Mar; 42(3):851-860. PubMed ID: 27770159
[TBL] [Abstract][Full Text] [Related]
10. Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy.
Xiong JJ; Nunes QM; Huang W; Pathak S; Wei AL; Tan CL; Liu XB
World J Gastroenterol; 2013 Dec; 19(46):8731-9. PubMed ID: 24379593
[TBL] [Abstract][Full Text] [Related]
11. Should more aggressive surgical resection be considered in the treatment for Bismuth types I and II hilar cholangiocarcinoma? A meta-analysis.
Hu YF; Hu HJ; Lv TR; He ZQ; Dai YS; Li FY
Asian J Surg; 2023 Oct; 46(10):4115-4123. PubMed ID: 36586821
[TBL] [Abstract][Full Text] [Related]
12.
Li X; Zhang Y; Zhang Y
BMC Geriatr; 2018 Jul; 18(1):150. PubMed ID: 29976141
[TBL] [Abstract][Full Text] [Related]
13. [Operation treatment method of Bismuth-Corlette Ⅲ, Ⅳ hilar cholangiocarcinoma].
Lu Z; Wang DD
Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):488-91. PubMed ID: 27373472
[TBL] [Abstract][Full Text] [Related]
14. [The safety and effect of transhepatic hilar approach for the treatment of bismuth type Ⅲ and Ⅳ hilar cholangiocarcinoma].
He M; Wang HL; Yan JY; Xu SW; Chen W; Wang J
Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):360-366. PubMed ID: 29779312
[No Abstract] [Full Text] [Related]
15. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
16. Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.
Xu ZL; Ou YJ; Dai HS; Wan K; Bie P; Chen ZY; Zhang LD; Zhang CC
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101695. PubMed ID: 34147661
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
Cannon RM; Brock G; Buell JF
HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
[TBL] [Abstract][Full Text] [Related]
18. Intraductal ultrasonography combined with percutaneous transhepatic cholangioscopy for the preoperative evaluation of longitudinal tumor extent in hilar cholangiocarcinoma.
Kim HM; Park JY; Kim KS; Park MS; Kim MJ; Park YN; Bang S; Song SY; Chung JB; Park SW
J Gastroenterol Hepatol; 2010 Feb; 25(2):286-92. PubMed ID: 19780880
[TBL] [Abstract][Full Text] [Related]
19. Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma.
Zeng N; Tao H; Fang C; Fan Y; Xiang N; Yang J; Zhu W; Liu J; Guan T; Fang C; Xiang F
World J Surg Oncol; 2016 Feb; 14(1):44. PubMed ID: 26911245
[TBL] [Abstract][Full Text] [Related]
20. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma.
Meng ZW; Lin XQ; Zhu JH; Han SH; Chen YL
J Surg Res; 2018 Jun; 226():56-63. PubMed ID: 29661289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
